Skip to content
10-Q

Quarterly Report

Apexigen, Inc.

0000950170-22-025024

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 10, 2022 22.57M sh
Shares Diluted Q3 2022 · Sep 30, 2022 20.48M sh
Shares Diluted Q3 2022 · Sep 30, 2022 18.9M sh
Shares Diluted Q3 2022 · Sep 30, 2021 18.04M sh
Shares Diluted Q3 2022 · Sep 30, 2021 18.03M sh
Capex Q3 2022 · Sep 30, 2022 $57K
Capex Q3 2022 · Sep 30, 2021 $54K
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$27.64M
Operating Cash Flow restated Q3 2022 · Sep 30, 2021 −$18.75M
Short Term Investments Q3 2022 · Sep 30, 2022 $7.97M
Short Term Investments Q3 2022 · Dec 31, 2021 $12.92M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $12.71M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $23.44M
Stockholders Equity Q3 2022 · Sep 30, 2022 $10.41M
Stockholders Equity Q3 2022 · Jun 30, 2022 $5.7M
Stockholders Equity Q3 2022 · Dec 31, 2021 $22M
Stockholders Equity restated Q3 2022 · Sep 30, 2021 $29.84M
Stockholders Equity restated Q3 2022 · Jun 30, 2021 $36.81M
Stockholders Equity restated Q3 2022 · Dec 31, 2020 $49.68M
Current Liabilities Q3 2022 · Sep 30, 2022 $17.13M
Current Liabilities Q3 2022 · Dec 31, 2021 $16.95M
Total Liabilities Q3 2022 · Sep 30, 2022 $17.16M
Total Liabilities Q3 2022 · Dec 31, 2021 $17.1M
Current Assets Q3 2022 · Sep 30, 2022 $24.99M
Current Assets Q3 2022 · Dec 31, 2021 $38.04M
Total Assets Q3 2022 · Sep 30, 2022 $27.57M
Total Assets Q3 2022 · Dec 31, 2021 $39.1M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.41
Eps Diluted Q3 2022 · Sep 30, 2022 −$1.36
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.40
Eps Diluted Q3 2022 · Sep 30, 2021 −$1.16
Eps Basic Q3 2022 · Sep 30, 2022 −$0.41
Eps Basic Q3 2022 · Sep 30, 2022 −$1.36
Eps Basic Q3 2022 · Sep 30, 2021 −$0.40
Eps Basic Q3 2022 · Sep 30, 2021 −$1.16
Sga Expense Q3 2022 · Sep 30, 2022 $3.12M
Sga Expense Q3 2022 · Sep 30, 2022 $7.24M
Sga Expense restated Q3 2022 · Sep 30, 2021 $1.81M
Sga Expense restated Q3 2022 · Sep 30, 2021 $5.74M
Rd Expense Q3 2022 · Sep 30, 2022 $5.68M
Rd Expense Q3 2022 · Sep 30, 2022 $18.8M
Rd Expense Q3 2022 · Sep 30, 2021 $5.5M
Rd Expense Q3 2022 · Sep 30, 2021 $15.12M
Net Income Q3 2022 · Sep 30, 2022 −$8.49M
Net Income Q3 2022 · Sep 30, 2022 −$25.64M
Net Income restated Q3 2022 · Sep 30, 2021 −$7.3M
Net Income restated Q3 2022 · Sep 30, 2021 −$20.82M
Operating Income Q3 2022 · Sep 30, 2022 −$8.8M
Operating Income Q3 2022 · Sep 30, 2022 −$26.04M
Operating Income restated Q3 2022 · Sep 30, 2021 −$7.31M
Operating Income restated Q3 2022 · Sep 30, 2021 −$20.86M